info@marketresearchfuture.com   ūüďě  +1 (855) 661-4441(US)   ūüďě  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

U.S. Personalized Medicine Market Research Report Information, by product (diagnostic, therapeutics, medical care and nutrition and wellness) by application (diagnosis and intervention, drug development and usage, cancer genomics and others), by End users (hospitals, molecular diagnostic laboratories and testing centers, academic institutes, bio and health informatics companies and others)- Forecast to 2030


ID: MRFR/Pharma/10195-HCR | 85 Pages | Author: Garvit Vyas| July 2024

U.S. Personalized Medicine Market Overview


The U.S. Personalized Medicine Market is expected to reach USD 27.45 Billion by 2030 at 8.6% CAGR during the forecast period 2022-2030.


The Personalized Medicine Market is the most recent trend in the multibillion–dollar molecular diagnostics industry. Pharmaceutical and biotechnology companies are increasingly turning to personalized medicine in order to improve the drug development process and also to speed up the approval or sanction of new drugs.


U.S. Personalized Medicine Market


According to the industry consensus, personalized medicine will not only form an integral part of typical medicine in the next few years, it is also anticipated to reform the development, testing, marketing and prescription of drugs during the next decade. The big pharmaceutical companies eventually will change their tried and tested epic business model to more–targeted and effective healthcare solutions. 


Study objectives:



  • To measure the U.S. personalized medicine market, which has experienced high growth year to year.

  • To analyze the current personalized medicine business model in United States and to evaluate the commercial use of the personalized medicine technology platform.

  • To analyze and forecast the market data for each sub-segment for the next 6 years.

  • To provide country level analysis of the market with respect to the current market size and future growth prospect.

  • To analyze individual submarkets for personalized medicine in the United States in terms of technology, products, services, application areas and geography.

  • To track and analyze developments which are competitive in nature such as joint ventures, strategic alliances, mergers and acquisitions, new product developments along with research and developments currently taking place  in the personalized medicine market of the U.S.


Key players of U.S. Personalized Medicine Market:



  • Laboratory Corporation of America

  • Quest Diagnostics

  • Abbott

  • Becton Dickinson & Co

  • Siemens Healthcare Diagnostics Inc

  • GE Healthcare

  • Pfizer Inc.

  • Sanofi

  • CardioDx Inc.

  • Asuragen Inc

  • Bristol-Myers Squibb


US Personalized Medicine Segment Insights


The U.S. Personalized Medicine Market is segmented on the basis of product, application and end users. Based on the product, the market has been segmented as diagnostic, therapeutics, medical care and nutrition and wellness and others. Based on application, the market has been segmented into diagnosis and intervention, drug development and usage, cancer genomics and others. Further on the basis of end users the market has been segmented as hospitals, molecular diagnostic laboratories and testing centers, academic institutes, bio and health informatics companies and others.


US Personalized Medicine Regional Insights


U.S. accounts for the maximum market share of the personalized medicine market and the market is expected to increase continuously in coming years. This can be attributed to increasing pool of cancer patients along with high healthcare per capita expenditure. Advancing technologies within the liquid biopsy or cancer market is also driving the market and will see strategic growth over the next five years. The two segments of the liquid biopsy market are tumor cell enrichment products and tumor cell detection technologies which are expected to command the maximum market share.


The report for U.S. Personalized Medicine Market by Market Research Future comprises of extensive primary research along with the detail analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain a deeper insight of the market and industry performance. The report gives a clear picture of current market scenario which includes past and estimated future market size with respect to value and volume, technological advancement, macro economical and governing factors in the market. The report provides detail information about and strategies used by top key players in the industry. The report also gives a broad study of the different market segments and regions. 


Intended Audience



  • U.S. Personalized medicine providers, manufacturers & suppliers

  • Contract Research Organizations (CROs)

  • Research and Development (R&D) companies

  • Government research laboratories

  • Independent research laboratories

  • Government and Independent regulatory authorities

  • Market research and consulting service providers

  • Academic institutes and universities

Report Attribute/Metric Details
  Market Size   USD 27.45 Billion
  CAGR   8.6%
  Base Year   2022
  Forecast Period   2023-2030
  Historical Data   2021
  Forecast Units   Value (USD Billion)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   By Product, End users, Application
  Geographies Covered   North America, US
  Key Vendors Laboratory Corporation of America, Quest Diagnostics, Abbott, Becton Dickinson & Co, Siemens Healthcare Diagnostics Inc, GE Healthcare,Pfizer Inc., Sanofi, CardioDx Inc., Asuragen Inc, Bristol-Myers Squibb
  Key Market Opportunities The rising prevalence of chronic diseases, such as cancer, diabetes, and cardiovascular disorders
  Key Market Drivers Increasing awareness among patients about personalized medicine


Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.